Background: In vitro evidence suggests that the p38 mitogen-activated protein kinase (p38 MAPK) plays a crucial role in PMN activation and inflammatory cytokine production. However, the effect of p38 MAPK on myocardial reperfusion injury, a pathologic condition involving a typical inflammatory response, has not been fully examined. In the present study, we investigated the effect of SB 239063, a specific p38 MAPK inhibitor, on myocardial injury in a murine ischemia / reperfusion (I / R) model and elucidated the mechanism by which p38 MAPK inhibitor may exert its protective effect against I / R injury. Methods and results: I / R resulted in a significant myocardial injury (myocardial infarct 4562.9%) and marked PMN accumulation (myeloperoxidase activity 1.0360.16 U / 100 g tissue). Administration of SB 239063 significantly inhibited the myocardial inflammatory response as evidenced by reduced PMN accumulation in I / R myocardial tissue (0.6260.008 U / 100 g tissue, P,0.01 vs. vehicle), and markedly attenuated myocardial reperfusion injury (myocardial infarct size: 2862.4%, P,0.01 vs. vehicle). Moreover, treatment with SB 239063 significantly attenuated I / R-induced P-selectin and ICAM-1 upregulation (13.862.7 vs. 23.963.1%, and 29.461.6 vs. 56.364.8%, respectively P,0.01). In addition, pre-treatment with R15.7, a monoclonal antibody against CD 18 adhesion molecule on PMN surface that virtually abolished PMN accumulation in ischemic-reperfused myocardial tissue, significantly, but not completely, blocked the cardioprotection exerted by SB 239063. Conclusion: These results demonstrated for the first time that p38 MAPK activation plays a significant role in adhesion molecule upregulation on ischemia-reperfused endothelial cells and is an important signaling step in the pathogenesis of PMN-mediated tissue injury.
Introduction
which polymorphonuclear leukocytes (PMNs) play an important role. Experimental interventions aimed at reducEarly reperfusion after coronary obstruction is the most ing PMN accumulation (PMN depletion, pharmacological effective means of limiting ischemic myocardial injury.
suppression of PMN activation, or administration of monoHowever, abundant evidence suggests that reperfusion may clonal antibodies against PMN or endothelial adhesion cause additional cell death (reperfusion injury). The promolecules) have been proven to exert significant protective cess of myocardial ischemia / reperfusion (MI / R) injury effects on ischemia-reperfusion-induced myocardial daminvolves components of a typical inflammatory reaction in age [1] [2] [3] [4] . Adhesion of PMNs to endothelial cells (ECs) is an early and requisite event in the inflammatory response. Current *Corresponding author. Tel.: 11-215-955-4994; fax: 11-215-923-evidence indicates that adhesion of PMNs to ECs involves 6225 .
E-mail address: xin.ma@mail.tju.edu (X.L. Ma). 1 The first two authors made an equal contribution to this study. Time for primary review 26 days.
several steps and requires multiple adhesion molecules on generation p38 MAPK inhibitor that has been demonthe surface of both cell types [5] . The initial interaction strated to be extremely selective for p38 MAPK (IC for   50 between PMNs and ECs is mediated by L-selectin and inhibition of p38 MAPK: 0.044 mM; for MEK1 / 2, ERK1 / P-selectin glycoprotein ligand-1 (PSGL-1) located on the 2 and SAPK: .10 mM) [17] . SB 239063 was administered PMN surface and P-selectin and E-selectin expressed on at a dose of 30 mg / kg, p.o., 20 min before the induction of the EC surface. This selectin-mediated interaction results myocardial ischemia. This is a dose regimen that comin the rolling of PMNs along the vessel wall and upregulapletely blocked p38 MAPK activation, decreased TNFa tion of b -integrin adhesion molecules on the PMN surface production, and reduced brain injury and neurological 2 [6] . Upregulated CD11 / CD18 adhesion molecules then deficits in cerebral focal ischemia [17] . Rats were anesbind to their counterreceptors on ECs, primarily intercelluthetized with pentobarbital sodium (35 mg / kg, i.p.) and lar adhesion molecule-1 (ICAM-1), resulting in their firm the trachea was cannulated with PE-240 tubing to insure a adhesion and transmigration through the vascular wall. patent airway. A midline thoracotomy was performed, the Although clear evidence exists demonstrating that adhesion heart was exposed, and myocardial ischemia was produced molecule expression by coronary endothelial cells is by placing a 4-0 silk slipknot around the left coronary markedly upregulated following myocardial ischemia and artery, approximately 2-3 mm from its origin. Ischemia reperfusion [7] , the signal transduction pathway leading to was maintained for 30 min, at which time the slipknot was this response is poorly understood.
released, initiating reperfusion. Sham operated control rats The mitogen-activated protein kinases (MAPKs) are a (Sham MI / R) underwent the same surgical procedures family of serine-threonine protein kinases that are actiexcept that the suture that was passed under the left vated in response to a variety of stimuli, such as growth coronary artery was not tied. After 10 min (for p38 MAPK factors and cellular stresses [8] . The three major MAPK activity), 20 min (for P-selectin immunolocalization), or 24 signaling pathways that have been identified in mammalian h of reperfusion (for ICAM-1 immunolocalization, cells involve extracellular signal-regulated protein kinases myocardial myeloperoxidase and myocardial infarct size), (ERK1 / 2), p38 MAPK and c-Jun NH -terminal protein the hearts were excised and processed according to the 2 kinases (JNKs) / stress-activated protein kinases (SAPKs). procedures described below for evaluation of myocardial Substantial evidence suggests that p38 MAPK plays a infarct size, myocardial myeloperoxidase (MPO) activity, crucial role in the PMN response to a variety of stimuli.
and adhesion molecule expression. Inhibition of p38 MAPK in vitro reduces CD11 / CD18 expression, PMN adhesion, and free radical generation 2.2. Determination of myocardial infarct size [9] [10] [11] [12] [13] [14] [15] [16] . However, to date, the role of p38 MAPK in adhesion molecule expression on the endothelial surface At the end of the 24-h reperfusion period, the ligature remains largely unexplored.
around the coronary artery was retied and 1 ml of 2% Therefore, the goals of the current study were: (1) to Evans blue dye was injected into the left ventricular cavity. determine whether p38 MAPK inhibition may exert its
The dye was circulated and uniformly distributed except in cardioprotective effects against reperfusion injury via that portion of the heart previously perfused by the inhibition of the myocardial inflammatory response; and if occluded coronary artery (area-at-risk, AAR). The heart so, (2) to investigate the mechanism by which p38 MAPK was quickly excised, frozen at 2208C, and sliced into inhibition may inhibit PMN / EC interaction.
1-mm-thick sections perpendicular to the long axis of the heart using a heart slice chamber. Slices were incubated individually using a 24-well culture plate in 1% TTC in 2. Methods phosphate buffer at pH 7.4 at 378C for 10 min, and photographed with a digital camera (160031200 dpi).
Experimental protocol
Evan's blue stained area (area-not-at-risk, ANAR), TTC stained area (red staining, ischemic but viable tissue), and The experiments were performed in adherence to Na-TTC staining negative area (infarct myocardium) were tional Institutes of Health Guidelines on the Use of digitally measured using SigmaScan. The myocardial Laboratory Animals and were approved by the Thomas infarct size was expressed as a percentage of infarct area Jefferson University Committee on Animal Care. Male over total AAR. Sprague-Dawley rats (200-250 g) were randomly divided into the following groups: sham MI / R rats (n528), MI / R 2.3. Determination of myocardial myeloperoxidase rats receiving vehicle (n529), MI / R rats receiving SB activity
Myeloperoxidase, an enzyme occurring virtually exclu-MI / R rats receiving R15.7 (a monoclonal antibody against sively in PMNs, was determined in cardiac tissue as CD18, 1 mg / kg, i.v., n512), and MI / R rats receiving described previously [18] . In brief, ischemic / reperfused R15.7 and SB239063 (n512). SB 239063 is a secondcardiac tissue was homogenized in 50 mmol / l potassium phosphate buffer at pH 6 containing 0.5% hexaderat ICAM-1 monoclonal antibody, 22491D, Pharmingen) cyltrimethyl ammonium bromide (HTAB). The homogeovernight at 48C in humidified chambers. After washing, nates were centrifuged for 30 min at 12 5003g and 48C.
the sections were incubated with biotinylated secondary The supernatants were then collected and reacted with antibody at room temperature for 1 h. Antibody-binding 0.167 mg / ml o-dianisodine dihydrochloride and 0.0005% sites were labeled and measured in the same manner as H O in 50 mmol / l phosphate buffer at pH 6. The that described above for P-selectin immunohistochemical 2 2 measurement was performed at 460 nm at 258C using a localization. microplate reader (SpectraMAX Plus, Molecular Devices, Sunnyvale, CA) in duplicate. One unit of MPO activity 2.6. p38 MAP kinase activity assay was defined as that quantity of enzyme hydrolyzing 1 mmol of peroxide per min at 258C.
The p38 MAP kinase activity assay was performed using a p38 MAPK assay kit (Cell Signaling Technology) 2.4. Immunohistochemical localization of P-selectin according to the manufacturer's instructions. In brief, ischemic / reperfused (30 min / 10 min) heart tissue (20-25 After 30 min of ischemia and 20 min of reperfusion, the mg) was homogenized in 0.5 ml ice-cold cell lysis buffer hearts were removed and the aorta was cannulated and (20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM perfused with KH buffer for 3 min at 50 mmHg. After the EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, heart was cleared of blood, perfusion was switched to 1 mM b-glycerolphosphate, 1 mM Na VO , 1 mg / ml 3 4
ice-cold 4% paraformaldehyde in PBS for 5 min to leupeptin, 1 mM PMSF). The lysates were then sonicated perfusion fix the hearts. Four full thickness slices of the on ice and centrifuged at 15 0003g for 10 min at 48C. ischemic and non-ischemic left ventricular wall were cut
Immunoprecipitation was performed by adding 20 ml of and immersed in 4% paraformaldehyde for 24 h. Afterresuspended immobilized monoclonal antibody against wards, they were processed (Leica TP1050 infiltration phospho-p38 MAP kinase (Thr180 / Tyr182) to 200 ml cell processor), embedded in paraffin (Leica EG 1140H lysate containing 500 mg protein. The mixture was incuBedienhinweise) and sectioned at 5-mm (Leica RM2035 bated with gentle rocking overnight at 48C. After cenMicrotome). The tissue sections were placed on Vectabondtrifuging at 10 0003g at 48C for 2 min, the pellets were coated slides (Vector Laboratories, Burlingame, CA).
washed twice with lysis buffer and twice with kinase Immunohistochemical localization of P-selectin was acbuffer (25 mM Tris, pH 7.5, 5 mM b-glycerophosphate, 2 complished using a rabbit anti-human P-selectin polyclonal mM DTT, 0.1 mM Na VO , 10 mN MgCl ). The kinase 3 4 2 antibody (09361A, Pharmingen, San Diego, CA) by the reactions were carried out in the presence of 200 mM ATP avidin-biotin immunoperoxidase technique (Vectastain and 2 mg ATF-2 fusion protein at 308C for 30 min. After ABC reagent; Vector Laboratories). Positive staining was incubation, the samples were separated by SDS-PAGE, defined as a venule displaying brown reaction product on and ATF-2 phosphorylation was measured by Western .50% of the circumference of its endothelium as previimmunoblotting using a monoclonal antibody against ously described [19, 20] . Ten sections from each heart and phosphorylated ATF-2 followed by an enhanced 20 venules per tissue section were examined, and the chemiluminescent detection. percentage of positive staining venules was then calculated.
Statistical analysis

Immunohistochemical localization of ICAM-1
All values in the text and figures are presented as means6standard errors (S.E.) of n independent experiIt has been previously reported by several investigators ments. All data were subjected to analysis of variance that ICAM-1 immunohistochemical localization cannot be (ANOVA) followed by the Scheffe's correction for postperformed using paraformaldehyde fixed tissue [21, 22] .
hoc t-test comparison. Probabilities of 0.05 or less were Frozen sections were thus used and stained according to considered to be statistically significant. the manufacturer's (Pharmingen) instructions. In brief, after 30 min of ischemia and 24 h of reperfusion, the hearts were removed and washed with ice-cold PBS. Four full 3. Results thickness slices of the ischemic and non-ischemic left ventricular wall were immediately embedded in OCT-3.1. Ischemia /reperfusion activation of p38 MAPK and compound and frozen in liquid nitrogen. Cryostat sections its blockade by SB 239063 of 6 mm thickness were cut, fixed in cold acetone and air-dried. The sections were pretreated for 10 min with Effect of in vivo myocardial ischemia and reperfusion 0.03% H O in PBS to quench endogenous peroxidase and on p38 MAPK activity and its inhibition by SB 239063 2 2 blocked with 5% normal serum. This was followed by was determined using a p38 MAPK assay kit. The data incubation with primary antibody (10 mg / ml mouse antishow that a transient (,30 min), moderate (two-to threefold) increase in p38 MAPK activity was observed in by reperfusion resulted in a significant myocardial infarct, the hearts subjected to ischemia without reperfusion (data which was significantly attenuated with SB 239063 treatnot shown). However, when ischemic myocardial tissue ment. was reperfused, p38 MAPK was markedly reactivated. A 4.5-fold increase in p38 MAPK activity was observed at 10 3.3. Effect of p38 MAPK inhibition on PMN min after reperfusion (Fig. 1) and its activity gradually accumulation in ischemic /reperfused cardiac tissue returned to control level thereafter. Treatment with SB 239063 at the dose regimen selected virtually abolished
To determine whether p38 MAPK inhibition may exert p38 MAPK activation and brought p38 MAPK activity to a its cardioprotective effects by inhibiting PMN accumulalevel that was not statistically different from those seen in tion and thus reducing PMN-induced myocardial injury, hearts subjected to sham MI / R (Fig. 1) . These results we measured MPO activity, an index that has been shown clearly demonstrated that p38 MAPK was activated by to correlate closely with PMN accumulation in the heart ischemia and reperfusion, and its activation can be in- [23] . As summarized in Fig. 3, 30 nificantly decreased PMN accumulation in ischemic / reexert significant cardioprotection against reperfusion inperfused cardiac tissue, suggesting that p38 MAPK inhibijury, we investigated the effect of SB 239063 treatment on tion exerted its protective effects partially through inhibmyocardial infarct size after 30 min of ischemia and 24 h iting PMN / EC interaction and subsequent inflammatory of reperfusion. As illustrated in Fig. 2 , ischemia followed injury to the myocardial tissue. 
Effect of p38 MAPK inhibition on EC surface ing PMN rolling, and ICAM-1, a critical molecule required expression of P-selectin and ICAM-1 following MI /R
for PMN firm adhesion and transmigration. The percentage of coronary venules staining positively for P-selectin and To further explore the mechanisms by which p38 ICAM-1 in sham MI / R rats was low (Fig. 4) . Thirty MAPK inhibition exerts its protection against PMN-inminutes of ischemia followed by 20 min of reperfusion duced myocardial injury following reperfusion, we studied resulted in a significant increase in the percentage of the effect of SB 239063 on endothelial surface expression venules staining positively for P-selectin in untreated of P-selectin, an early-response adhesion molecule mediatischemic / reperfused rats (Fig. 4) . Treatment with SB 239063 at a dose that blocked p38 MAPK activation after ischemia and reperfusion reduced positive staining (13.862.7%). This represented a 51% inhibition of Pselectin upregulation in rats receiving only vehicle. In rats exposed to 30 min of ischemia and 24 h of reperfusion and receiving only vehicle, ICAM-1 positive staining increased 4.5-fold compared to staining in sham MI / R rat venules (Fig. 4) . This increase in percentage of venules staining positively for ICAM-1 was markedly reduced in rats treated with SB 239063 (Fig. 4) . A previous study has demonstrated that endothelial surface ICAM-1 expression is significantly upregulated as early as 4.5 h after reperfusion, and reached the maximal level at 24 h after reperfusion [7] . To determine whether treatment with SB 239063 also attenuates the early phase of ICAM-1 upregulation, 19.862.6 vs. 42.363.9% in vehicle-treated animals, P, with SB 239063 in addition to R15.7 did not have a 0.01).
significant effect on myocardial MPO activity, this treatment further reduced myocardial infarct size to a level that 3.5. Contribution of anti-inflammatory effect of SB was significantly smaller than those hearts treated with 239063 on its overall cardioprotection after in vivo R15.7 alone (Fig. 2) . These results suggest that although myocardial ischemia and reperfusion the anti-adhesion and anti-inflammatory effects of p38 MAPK inhibition is largely responsible for observed Several previous studies, including one from our laboracardioprotection in this in vivo myocardial ischemia and tory, demonstrated that inhibition of p38 MAPK exerts reperfusion model, there is an additional PMN-independent significant cardioprotection in isolated hearts perfused with component that contributes to its overall cardioprotection crystalloid solution without PMNs, indicating that activaagainst reperfusion injury. tion of p38 MAPK can also induce myocardial injury via mechanisms that are independent of PMNs [24] [25] [26] [27] . To determine the relative contribution of PMN-dependent and 4. Discussion PMN-independent components of p38 MAPK activation on reperfusion injury, another two groups of animals were
The present study demonstrated that blockade of p38 studied. The first group of rats were treated with R15.7 (1 MAPK: (1) reduced ischemia-reperfusion-induced mg / kg, i.v., 20 min before coronary artery occlusion), a myocardial infarct; (2) attenuated PMN accumulation in monoclonal antibody against CD18 that has been demonischemic-reperfused myocardial tissue; and (3) inhibited strated to block PMN adhesion and reduce myocardial P-selectin and ICAM-1 surface expression in ischemicreperfusion injury in rat [28] . The second group of rats reperfused coronary endothelial cells. To our knowledge, were treated with a combination of R15.7 and SB 239063.
this is the first study that has: (1) investigated the role of Consistent with previously published results [28] , treatp38 MAPK in signal transduction leading to adhesion ment with R15.7 virtually abolished the increase in molecule expression in ischemic-reperfused coronary myocardial MPO activity, and markedly reduced infarct endothelial cells in vivo and (2) demonstrated that p38 size (Figs. 2 and 3 al. [12] and Partrick et al. [14] reported that p38 MAPK provides the first in vivo evidence that p38 MAPK is a key activation is required for priming of the PMN respiratory component in signal transduction leading to ICAM-1 burst in response to TNFa. In addition, Johnson et al. [11] upregulation in coronary endothelial cells exposed to demonstrated that two members of the MAPK family, p38 ischemia and reperfusion. Considerable evidence exists MAPK and ERK, are activated in fMLP-stimulated PMNs.
that myocardial ischemia followed by reperfusion increases However, the roles of p38 MAPK and ERK in PMN cytokine production, and this increased cytokine productcytotoxicity were opposite. . Taken saline inhibits CD11 / CD18 upregulation in agonist-stimutogether, it is conceivable that treatment with SB 239063 lated PMNs in a p38 MAPK-dependent fashion [16, 15, 10] .
in rats subjected to myocardial ischemia and reperfusion Taken together, these results demonstrate that p38 MAPK may reduce cytokine production, thus attenuating ICAM-1 plays a crucial role in signal transduction in PMNs expression. following their binding with P-selectin on the endothelial A previous study has demonstrated that in cultured surface. However, the role of p38 MAPK in P-selectin endothelial cells stimulated with TNFa, blockade of p38 surface expression by endothelial cells has not been MAPK resulted in a 40% reduction in ICAM-1 upregulapreviously elucidated.
tion [9] . However, the physiologic significance of this In the present study, we have provided direct evidence partial reduction of adhesion molecules remains unclear. that p38 MAPK also plays a crucial role in the signal Specifically, a concern has been expressed as to whether or transduction leading to P-selectin translocation in endonot this incomplete down-regulation of ICAM-1 expression thelial cells. We have demonstrated for the first time that is sufficient to cause a significant reduction in PMN-EC treatment with SB 239063, a highly specific p38 MAPK interaction. In the present study, we have demonstrated inhibitor, markedly attenuated P-selectin expression in that administration of SB 239063 significantly reduced coronary endothelial cells exposed to 30 min of ischemia MPO activity, a reliable index of PMN accumulation in and 20 min of reperfusion. These results suggest that p38 ischemic-reperfused cardiac tissue. This result provides MAPK may increase P-selectin-dependent PMN-EC interdirect evidence that inhibition of adhesion molecule exactions in at least two ways. First, p38 MAPK activation pression by blockade of p38 MAPK signaling indeed leads to P-selectin translocation in ischemic / reperfused causes a significant reduction in PMN-EC interaction. To coronary endothelial cells, thus facilitating PMN rolling further determine whether inhibition of adhesion molecule along the endothelial surface. Second, p38 MAPK particiexpression and reduction of PMN accumulation may pates in selectin-b -integrin cross-talk and upregulates reduce myocardial reperfusion injury, we investigated the 2 CD11 / CD18 expression on PMN surfaces, thus increasing effects of SB 239063 on myocardial infarct after ischemia integrin / ICAM-1-dependent PMN adhesion. and reperfusion. Our data clearly demonstrate that inhibiAnother interesting finding of the present study is that tion of p38 MAPK markedly attenuated ischemia-reperblockade of p38 MAPK activation inhibited ICAM-1 fusion-induced myocardial injury as evidenced by reduced expression in ischemic / reperfused coronary endothelial myocardial infarct size in SB 239063-treated animals. cells. Although existing data uniformly support the concluIt needs to be stressed that the cardioprotection elicited by blocking intracellular signal transduction pathways
